unlikely dividend because it seems the company has absorbed franking credits. I would think fund will be:
- invested to accelerate sales of branded portfolio
- search for complementary investments
SA facility seems to be grossly underperforming. But not surprised as not many pharmaceutical manufacturers have survived the AU operating environment- cost base are too high.
Ann: MYX completes sale of US retail generics business for US$90m, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.23 |
Change
0.070(1.36%) |
Mkt cap ! $424.1M | |||
| Open | High | Low | Value | Volume |
| $5.17 | $5.25 | $5.12 | $757.8K | 146.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1318 | $5.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.24 | 4268 | 22 |
View Market Depth
| Last trade - 14.24pm 22/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |